Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases (original) (raw)

• Taylor, C. T. & McElwain, J. C. Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology 25, 272–279 (2010).
  CAS PubMed Google Scholar
• Semenza, G. L. & Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447–5454 (1992).
  CAS PubMed PubMed Central Google Scholar
• Wang, G., Jiang, B., Rue, E. & Semenza, G. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510–5514 (1995).
  CAS PubMed PubMed Central Google Scholar
• Firth, J. D., Ebert, B. L., Pugh, C. W. & Ratcliffe, P. J. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl Acad. Sci. USA 91, 6496–6500 (1994).
  CAS PubMed PubMed Central Google Scholar
• Semenza, G. L., Roth, P. H., Fang, H. M. & Wang, G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757–23763 (1994). Landmark paper that identified binding of a hypoxia-inducible transcription factor, which binds to the erythropietin promoter and was subsequently named HIF.
  CAS PubMed Google Scholar
• Taylor, C. T. Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic inflammation. J. Physiol. 586, 4055–4059 (2008).
  CAS PubMed PubMed Central Google Scholar
• Schofield, C. J. & Ratcliffe, P. J. Oxygen sensing by HIF hydroxylases. Nature Rev. Mol. Cell Biol. 5, 343–354 (2004).
  CAS Google Scholar
• Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399–408 (2012).
  CAS PubMed PubMed Central Google Scholar
• Semenza, G. L. Oxygen sensing, homeostasis, and disease. N. Engl. J. Med. 365, 537–547 (2011).
  CAS PubMed Google Scholar
• Eltzschig, H. K. & Eckle, T. Ischemia and reperfusion — from mechanism to translation. Nature Med. 17, 1391–1401 (2011).
  CAS PubMed Google Scholar
• Eltzschig, H. K., Sitkovsky, M. V. & Robson, S. C. Purinergic signaling during inflammation. N. Engl. J. Med. 367, 2322–2333 (2012).
  CAS PubMed PubMed Central Google Scholar
• Eltzschig, H. K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656–665 (2011).
  CAS PubMed PubMed Central Google Scholar
• Zhang, H. et al. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc. Natl Acad. Sci. USA 105, 19579–19586 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kaelin, W. G. Jr & Ratcliffe, P. J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393–402 (2008).
  CAS PubMed Google Scholar
• Semenza, G. L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 24, 97–106 (2009).
  CAS PubMed Google Scholar
• Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999).
  CAS PubMed Google Scholar
• Tanimoto, K., Makino, Y., Pereira, T. & Poellinger, L. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19, 4298–4309 (2000).
  CAS PubMed PubMed Central Google Scholar
• Epstein, A. C. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). Landmark paper that identified mammalian PHDs in their functional role of regulating the stability of HIF.
  CAS PubMed Google Scholar
• Jaakkola, P. et al. Targeting of HIF-α to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468–472 (2001).
  CAS PubMed Google Scholar
• Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. & Murray, L. W. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295, 858–861 (2002).
  CAS PubMed Google Scholar
• Ema, M. et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl Acad. Sci. USA 94, 4273–4278 (1997).
  CAS PubMed PubMed Central Google Scholar
• Gu, Y. Z., Moran, S. M., Hogenesch, J. B., Wartman, L. & Bradfield, C. A. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α. Gene Expr. 7, 205–213 (1998).
  CAS PubMed Google Scholar
• Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H. & Poellinger, L. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α locus. J. Biol. Chem. 277, 32405–32408 (2002).
  CAS PubMed Google Scholar
• Makino, Y. et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550–554 (2001).
  CAS PubMed Google Scholar
• Bruick, R. K. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 17, 2614–2623 (2003).
  CAS PubMed Google Scholar
• Mikus, P. & Zundel, W. COPing with hypoxia. Semin. Cell Dev. Biol. 16, 462–473 (2005).
  CAS PubMed PubMed Central Google Scholar
• Boh, B. K., Smith, P. G. & Hagen, T. Neddylation-induced conformational control regulates cullin RING ligase activity in vivo. J. Mol. Biol. 409, 136–145 (2011).
  CAS PubMed Google Scholar
• Soucy, T. A. et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458, 732–736 (2009).
  CAS PubMed Google Scholar
• Khoury, J., Ibla, J. C., Neish, A. S. & Colgan, S. P. Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J. Clin. Invest. 117, 703–711 (2007).
  CAS PubMed PubMed Central Google Scholar
• Ehrentraut, S. F. et al. Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response. J. Immunol. 190, 392–400 (2013).
  CAS PubMed Google Scholar
• Abraham, C. & Cho, J. H. Inflammatory bowel disease. N. Engl. J. Med. 361, 2066–2078 (2009).
  CAS PubMed PubMed Central Google Scholar
• Colgan, S. P. & Eltzschig, H. K. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu. Rev. Physiol. 74, 153–175 (2012).
  CAS PubMed Google Scholar
• Colgan, S. P. & Taylor, C. T. Hypoxia: an alarm signal during intestinal inflammation. Nature Rev. Gastroenterol. Hepatol 7, 281–287 (2010).
  Google Scholar
• Karhausen, J. O. et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114, 1098–1106 (2004).
  CAS PubMed PubMed Central Google Scholar
• Clambey, E. T. et al. Hypoxia-inducible factor-1α-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl Acad. Sci. USA 109, E2784–E2793 (2012).
  CAS PubMed PubMed Central Google Scholar
• Peyssonnaux, C. et al. Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516–7519 (2007).
  CAS PubMed Google Scholar
• Kuhlicke, J., Frick, J. S., Morote-Garcia, J. C., Rosenberger, P. & Eltzschig, H. K. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2, e1364 (2007).
  PubMed PubMed Central Google Scholar
• Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013).
  CAS PubMed PubMed Central Google Scholar
• Werth, N. et al. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE 5, e11576 (2010).
  PubMed PubMed Central Google Scholar
• Hartmann, H. et al. Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology 134, 756–767 (2008).
  CAS PubMed Google Scholar
• Kempf, V. A. et al. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 111, 1054–1062 (2005).
  CAS PubMed Google Scholar
• Haeberle, H. A. et al. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS ONE 3, e3352 (2008).
  PubMed PubMed Central Google Scholar
• Nizet, V. & Johnson, R. S. Interdependence of hypoxic and innate immune responses. Nature Rev. Immunol. 9, 609–617 (2009).
  CAS Google Scholar
• Peyssonnaux, C. et al. HIF-1α expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115, 1806–1815 (2005).
  CAS PubMed PubMed Central Google Scholar
• Rius, J. et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453, 807–811 (2008).
  CAS PubMed PubMed Central Google Scholar
• Grocott, M. P. et al. Arterial blood gases and oxygen content in climbers on Mount Everest. N. Engl. J. Med. 360, 140–149 (2009).
  CAS PubMed Google Scholar
• Hartmann, G. et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12, 246–252 (2000).
  CAS PubMed Google Scholar
• Synnestvedt, K. et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993–1002 (2002).
  CAS PubMed PubMed Central Google Scholar
• Schmit, M. A. et al. Vasodilator phosphostimulated protein (VASP) protects endothelial barrier function during hypoxia. Inflammation 35, 566–573 (2012).
  CAS PubMed Google Scholar
• Cummins, E. P. et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc. Natl Acad. Sci. USA 103, 18154–18159 (2006). An important study that identified a functional role of PHDs in the stabilization of nuclear factor κB under hypoxic conditions.
  CAS PubMed PubMed Central Google Scholar
• Campbell, E. L. et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40, 66–77 (2014).
  CAS PubMed PubMed Central Google Scholar
• Xavier, R. J. & Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427–434 (2007).
  CAS PubMed Google Scholar
• Marks, D. J., Rahman, F. Z., Sewell, G. W. & Segal, A. W. Crohn's disease: an immune deficiency state. Clin. Rev. Allergy Immunol. 38, 20–31 (2010).
  CAS PubMed PubMed Central Google Scholar
• Taylor, C. T. & Colgan, S. P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295–1300 (2007).
  PubMed Google Scholar
• Huang, J. S. et al. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. Clin. Gastroenterol. Hepatol. 2, 690–695 (2004).
  CAS PubMed Google Scholar
• Hart, M. L. et al. Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5′-nucleotidase (CD73) and the A2B adenosine receptor. J. Immunol. 186, 4367–4374 (2011).
  CAS PubMed Google Scholar
• Xue, X. et al. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology 145, 831–841 (2013).
  CAS PubMed Google Scholar
• Tambuwala, M. M. et al. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 139, 2093–2101 (2010).
  CAS PubMed Google Scholar
• Shah, Y. M. et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134, 2036–2048 (2008).
  PubMed Google Scholar
• Aherne, C. M. et al. Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis. Gut 61, 695–705 (2012).
  CAS PubMed Google Scholar
• Frick, J. S. et al. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J. Immunol. 182, 4957–4964 (2009).
  CAS PubMed Google Scholar
• Eltzschig, H. K., Rivera-Nieves, J. & Colgan, S. P. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin. Ther. Targets 13, 1267–1277 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ehrentraut, H. et al. CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. FASEB J. 27, 2207–2219 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ehrentraut, H., Westrich, J. A., Eltzschig, H. K. & Clambey, E. T. Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation. PLoS ONE 7, e32416 (2012).
  CAS PubMed PubMed Central Google Scholar
• Xiao, C. & Rajewsky, K. MicroRNA control in the immune system: basic principles. Cell 136, 26–36 (2009).
  CAS PubMed Google Scholar
• Fraisl, P., Aragones, J. & Carmeliet, P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nature Rev. Drug Discov. 8, 139–152 (2009).
  CAS Google Scholar
• Cummins, E. P. et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134, 156–165 (2008).
  CAS PubMed Google Scholar
• Robinson, A. et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134, 145–155 (2008).
  CAS PubMed Google Scholar
• Keely, S. et al. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis. Mucosal Immunol. 22, 114–123 (2013).
  Google Scholar
• Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121–1135 (2007).
  CAS PubMed Google Scholar
• Murry, C. E., Jennings, R. B. & Reimer, K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124–1136 (1986).
  CAS PubMed Google Scholar
• Kohler, D. et al. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116, 1784–1794 (2007).
  PubMed Google Scholar
• Eckle, T. et al. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115, 1581–1590 (2007).
  CAS PubMed Google Scholar
• Eckle, T. et al. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291, H2533–H2540 (2006).
  CAS PubMed Google Scholar
• Eltzschig, H. K. Adenosine: an old drug newly discovered. Anesthesiology 111, 904–915 (2009).
  CAS PubMed Google Scholar
• Eckle, T., Kohler, D., Lehmann, R., El Kasmi, K. C. & Eltzschig, H. K. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118, 166–175 (2008).
  CAS PubMed Google Scholar
• Eltzschig, H. K., Bonney, S. K. & Eckle, T. Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol. Med. 19, 345–354 (2013).
  CAS PubMed PubMed Central Google Scholar
• Eckle, T. et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nature Med. 18, 774–782 (2012).
  CAS PubMed Google Scholar
• Botker, H. E. et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375, 727–734 (2010).
  PubMed Google Scholar
• Cai, Z., Luo, W., Zhan, H. & Semenza, G. L. Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc. Natl Acad. Sci. USA 110, 17462–17467 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kharbanda, R. K., Nielsen, T. T. & Redington, A. N. Translation of remote ischaemic preconditioning into clinical practice. Lancet 374, 1557–1565 (2009).
  PubMed Google Scholar
• Ali, Z. A. et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 116 (11 Suppl.), I98–I105 (2007).
  PubMed Google Scholar
• Eckle, T. et al. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury. FASEB J. 27, 3078–3089 (2013).
  CAS PubMed PubMed Central Google Scholar
• Schingnitz, U. et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 184, 5271–5279 (2010).
  CAS PubMed Google Scholar
• Eckle, T., Koeppen, M. & Eltzschig, H. K. Role of extracellular adenosine in acute lung injury. Physiology 24, 298–306 (2009).
  CAS PubMed Google Scholar
• Eckle, T. et al. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111, 2024–2035 (2008).
  CAS PubMed PubMed Central Google Scholar
• Eckle, T., Grenz, A., Laucher, S. & Eltzschig, H. K. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest. 118, 3301–3315 (2008).
  CAS PubMed PubMed Central Google Scholar
• Dengler, V., Downey, G. P., Tuder, R. M., Eltzschig, H. K. & Schmidt, E. P. Neutrophil intercellular communication in acute lung injury: emerging roles of microparticles and gap junctions. Am. J. Respir. Cell. Mol. Biol. 49, 1–5 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ware, L. B. & Matthay, M. A. The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334–1349 (2000).
  CAS PubMed Google Scholar
• Ranieri, V. M. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526–2533 (2012).
  PubMed Google Scholar
• Herridge, M. S. et al. Functional disability 5 years after acute respiratory distress syndrome. N. Engl. J. Med. 364, 1293–1304 (2011).
  CAS PubMed Google Scholar
• Sitkovsky, M. & Lukashev, D. Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors. Nature Rev. Immunol. 5, 712–721 (2005).
  CAS Google Scholar
• Sitkovsky, M. V. et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22, 657–682 (2004).
  CAS PubMed Google Scholar
• Thiel, M. et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3, e174 (2005). An important study indicating that hyperoxic conditions — which may be necessary for the treatment of patients with ALI to maintain oxygenation of different tissues — can be detrimental via inhibition of anti-inflammatory and tissue-protective functions of HIFs.
  PubMed PubMed Central Google Scholar
• Eckle, T. et al. HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol. 11, e1001665 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kominsky, D. J., Campbell, E. L. & Colgan, S. P. Metabolic shifts in immunity and inflammation. J. Immunol. 184, 4062–4068 (2010).
  CAS PubMed Google Scholar
• Cramer, T. et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645–657 (2003).
  CAS PubMed PubMed Central Google Scholar
• Kojima, H. et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α -deficient chimeric mice. Proc. Natl Acad. Sci. USA 99, 2170–2174 (2002).
  CAS PubMed PubMed Central Google Scholar
• Okumura, C. Y. et al. A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. J. Mol. Med. 28, 1079–1089 (2012).
  Google Scholar
• Warnecke, C. et al. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB J. 17, 1186–1188 (2003).
  CAS PubMed Google Scholar
• Schaible, B. et al. Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS ONE. 8, e56491 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kelly, C. J. et al. Fundamental role for HIF-1α in constitutive expression of human βdefensin-1. Mucosal Immunol. 6, 6 (2013).
  Google Scholar
• Pazgier, M., Hoover, D. M., Yang, D., Lu, W. & Lubkowski, J. Human β-defensins. Cell. Mol. Life Sci. 63, 1294–1313 (2006).
  CAS PubMed Google Scholar
• Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nature Rev. Immunol. 3, 710–720 (2003).
  CAS Google Scholar
• Schroeder, B. O. et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature 469, 419–423 (2011).
  CAS PubMed Google Scholar
• Harder, J., Bartels, J., Christophers, E. & Schroder, J. M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707–5713 (2001).
  CAS PubMed Google Scholar
• O'Neil, D. A. et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163, 6718–6724 (1999).
  CAS PubMed Google Scholar
• Zhao, C., Wang, I. & Lehrer, R. I. Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396, 319–322 (1996).
  CAS PubMed Google Scholar
• Peyrin-Biroulet, L. et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc. Natl Acad. Sci. USA 107, 8772–8777 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kocsis, A. K. et al. Association of β-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand. J. Gastroenterol. 43, 299–307 (2008).
  CAS PubMed Google Scholar
• Wehkamp, J. et al. Inducible and constitutive β-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 9, 215–223 (2003).
  Google Scholar
• Jurevic, R. J., Bai, M., Chadwick, R. B., White, T. C. & Dale, B. A. Single-nucleotide polymorphisms (SNPs) in human β-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J. Clin. Microbiol. 41, 90–96 (2003).
  CAS PubMed PubMed Central Google Scholar
• Schaefer, A. S. et al. A 3′ UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun. 11, 45–54 (2010).
  CAS PubMed Google Scholar
• Ozturk, A., Famili, P. & Vieira, A. R. The antimicrobial peptide DEFB1 is associated with caries. J. Dent. Res. 89, 631–636 (2010).
  CAS PubMed Google Scholar
• Peyssonnaux, C. et al. Critical role of HIF-1α in keratinocyte defense against bacterial infection. J. Invest. Dermatol. 128, 1964–1968 (2008).
  CAS PubMed Google Scholar
• Steinbrech, D. S. et al. Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation. J. Surg. Res. 84, 127–133 (1999).
  CAS PubMed Google Scholar
• Tandara, A. A. & Mustoe, T. A. Oxygen in wound healing — more than a nutrient. World J. Surg. 28, 294–300 (2004).
  PubMed Google Scholar
• Furuta, G. T. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027–1034 (2001).
  CAS PubMed PubMed Central Google Scholar
• Louis, N. A. et al. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J. Cell Biochem. 99, 1616–1627 (2006).
  CAS PubMed Google Scholar
• Elson, D. A., Ryan, H. E., Snow, J. W., Johnson, R. & Arbeit, J. M. Coordinate up-regulation of hypoxia inducible factor (HIF)-1α and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 60, 6189–6195 (2000).
  CAS PubMed Google Scholar
• Albina, J. E. et al. HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am. J. Physiol. Cell Physiol. 281, C1971–1977 (2001).
  CAS PubMed Google Scholar
• Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992).
  CAS PubMed Google Scholar
• Glover, L. E. et al. Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis. Proc. Natl Acad. Sci. USA 110, 19820–19825 (2013).
  CAS PubMed PubMed Central Google Scholar
• Clavien, P. A., Petrowsky, H., DeOliveira, M. L. & Graf, R. Strategies for safer liver surgery and partial liver transplantation. N. Engl. J. Med. 356, 1545–1559 (2007).
  PubMed Google Scholar
• Pirenne, J. et al. Influence of ischemia-reperfusion injury on rejection after liver transplantation. Transplant. Proc. 29, 366–367 (1997).
  CAS PubMed Google Scholar
• Watt, K. D., Lyden, E. R., Gulizia, J. M. & McCashland, T. M. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Liver Transpl. 12, 134–139 (2006).
  PubMed Google Scholar
• Schneider, M. et al. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury. Gastroenterology 138, 1143–1154 (2010).
  CAS PubMed Google Scholar
• Chouker, A. et al. In vivo hypoxic preconditioning protects from warm liver ischemia–reperfusion injury through the adenosine A2B receptor. Transplantation 94, 894–902 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hart, M. L. et al. Extracellular adenosine production by ecto-5′-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 135, 1739.e3–1750.e3 (2008).
  Google Scholar
• Cheng, K. et al. Hypoxia-inducible factor-1α regulates β cell function in mouse and human islets. J. Clin. Invest. 120, 2171–2183 (2010).
  CAS PubMed PubMed Central Google Scholar
• Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69–82 (2014).
  PubMed Google Scholar
• Kebir, H. et al. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nature Med. 13, 1173–1175 (2007).
  CAS PubMed Google Scholar
• Dang, E. V. et al. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 146, 772–784 (2011).
  CAS PubMed PubMed Central Google Scholar
• Shi, L. Z. et al. HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and TReg cells. J. Exp. Med. 208, 1367–1376 (2011).
  CAS PubMed PubMed Central Google Scholar
• O'Connor, W. Jr et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nature Immunol. 10, 603–609 (2009).
  CAS Google Scholar
• Ben-Shoshan, J., Maysel-Auslender, S., Mor, A., Keren, G. & George, J. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α. Eur. J. Immunol. 38, 2412–2418 (2008).
  CAS PubMed Google Scholar
• Bartels, K., Karhausen, J., Clambey, E. T., Grenz, A. & Eltzschig, H. K. Perioperative organ injury. Anesthesiology 119, 1474–1489 (2013).
  PubMed Google Scholar
• Park, S. W. et al. Paneth cell-mediated multiorgan dysfunction after acute kidney injury. J. Immunol. 189, 5421–5433 (2012).
  CAS PubMed Google Scholar
• Gelman, S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 82, 1026–1060 (1995).
  CAS PubMed Google Scholar
• Schrier, R. W. & Wang, W. Acute renal failure and sepsis. N. Engl. J. Med. 351, 159–169 (2004).
  CAS PubMed Google Scholar
• Bove, T. et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 111, 3230–3235 (2005).
  CAS PubMed Google Scholar
• Kumar, A. B. & Suneja, M. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology 114, 964–970 (2011).
  PubMed Google Scholar
• Hill, P. et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 19, 39–46 (2008).
  CAS PubMed PubMed Central Google Scholar
• Grenz, A. et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 5, e137 (2008).
  PubMed PubMed Central Google Scholar
• Kapitsinou, P. P. et al. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J. Clin. Invest. 124, 2396–2409 (2014). An important study that, for the first time, implicates kidney protection by HIF2α expressed in vascular endothelial cells.
  CAS PubMed PubMed Central Google Scholar
• Mole, D. R. et al. 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg. Med. Chem. Lett. 13, 2677–2680 (2003).
  CAS PubMed Google Scholar
• Masson, N. & Ratcliffe, P. J. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels. J. Cell Sci. 116, 3041–3049 (2003).
  CAS PubMed Google Scholar
• Chan, D. A., Sutphin, P. D., Yen, S. E. & Giaccia, A. J. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1α. Mol. Cell. Biol. 25, 6415–6426 (2005).
  CAS PubMed PubMed Central Google Scholar
• Kong, D. et al. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res. 65, 9047–9055 (2005).
  CAS PubMed Google Scholar
• Wang, R., Zhou, S. & Li, S. Cancer therapeutic agents targeting hypoxia-inducible factor-1. Curr. Med. Chem. 18, 3168–3189 (2011).
  CAS PubMed Google Scholar
• Xia, Y., Choi, H. K. & Lee, K. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Eur. J. Med. Chem. 49, 24–40 (2012).
  CAS PubMed Google Scholar
• Ku, J. H. et al. Effect of dutasteride on the expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and microvessel density in rat and human prostate tissue. Scand. J. Urol. Nephrol. 43, 445–453 (2009).
  CAS PubMed Google Scholar
• Puppo, M. et al. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1α and -2α. Mol. Cancer Ther. 7, 1974–1984 (2008).
  CAS PubMed Google Scholar
• Palayoor, S. T. et al. PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells. Int. J. Cancer 123, 2430–2437 (2008).
  CAS PubMed PubMed Central Google Scholar
• Rey, S. et al. Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc. Natl Acad. Sci. USA 106, 20399–20404 (2009).
  CAS PubMed PubMed Central Google Scholar
• Aragones, J. et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nature Genet. 40, 170–180 (2008). A study providing critically important insights into mechanisms of PHD-dependent tissue protection during ischaemia. Indeed, the authors found that PHD1 deletion and concomittant elevation in HIFs is associated with improved metabolic responses, thereby promoting hypoxia or ischaemia tolerance.
  CAS PubMed Google Scholar
• Rajagopalan, S. et al. Use of a constitutively active hypoxia-inducible factor-1α transgene as a therapeutic strategy in no-option critical limb ischemia patients: Phase I dose-escalation experience. Circulation 115, 1234–1243 (2007).
  CAS PubMed Google Scholar
• Creager, M. A. et al. Effect of hypoxia-inducible factor-1α gene therapy on walking performance in patients with intermittent claudication. Circulation 124, 1765–1773 (2011).
  CAS PubMed Google Scholar
• Bernhardt, W. M. et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J. Am. Soc. Nephrol. 21, 2151–2156 (2010). The first published clinical trial that successfully uses a PHD inhibitor in patients to achieve HIF stabilization and concomitant increases in erythropoitin production.
  CAS PubMed PubMed Central Google Scholar
• Flight, M. H. Deal watch: AstraZeneca bets on FibroGen's anaemia drug. Nature Rev. Drug Discov. 12, 730 (2013).
  Google Scholar
• Macdougall, I. C. New anemia therapies: translating novel strategies from bench to bedside. Am. J. Kidney Dis. 59, 444–451 (2012).
  PubMed Google Scholar
• Semenza, G. L. Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3, 721–732 (2003).
  CAS Google Scholar
• Kaelin, W. G. Von Hippel–Lindau disease. Annu. Rev. Pathol. 2, 145–173 (2007). An important review paper that summarizes the discovery and functional role of the VHL gene in the post-translational regulation of HIF levels.
  CAS PubMed Google Scholar
• Fraisl, P., Mazzone, M., Schmidt, T. & Carmeliet, P. Regulation of angiogenesis by oxygen and metabolism. Dev. Cell 16, 167–179 (2009).
  CAS PubMed Google Scholar
• Liao, D. & Johnson, R. S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26, 281–290 (2007).
  CAS PubMed Google Scholar
• Pouyssegur, J., Dayan, F. & Mazure, N. M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437–443 (2006).
  CAS PubMed Google Scholar
• Mazzone, M. et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839–851 (2009).
  CAS PubMed PubMed Central Google Scholar
• Galluzzi, L., Kepp, O., Heiden, M. G. & Kroemer, G. Metabolic targets for cancer therapy. Nature Rev. Drug Discov. 12, 829–846 (2013).
  CAS Google Scholar
• Semenza, G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625–634 (2009).
  PubMed PubMed Central Google Scholar
• Asikainen, T. M. et al. Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity. FASEB J. 20, 1698–1700 (2006).
  CAS PubMed Google Scholar
• Hams, E. et al. The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells. Shock 36, 295–302 (2011).
  CAS PubMed PubMed Central Google Scholar
• Percy, M. J. et al. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N. Engl. J. Med. 358, 162–168 (2008).
  CAS PubMed PubMed Central Google Scholar
• Simonson, T. S. et al. Genetic evidence for high-altitude adaptation in Tibet. Science 329, 72–75 (2010).
  CAS PubMed Google Scholar
• Higgins, D. F. et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117, 3810–3820 (2007).
  CAS PubMed PubMed Central Google Scholar
• Kastelein, J. J. et al. Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation 114, 1729–1735 (2006).
  CAS PubMed Google Scholar
• Takeda, N. et al. Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24, 491–501 (2010).
  CAS PubMed PubMed Central Google Scholar
• Keith, B., Johnson, R. S. & Simon, M. C. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nature Rev. Cancer 12, 9–22 (2012).
  CAS Google Scholar
• Branco-Price, C. et al. Endothelial cell HIF-1α and HIF-2α differentially regulate metastatic success. Cancer Cell 21, 52–65 (2012).
  CAS PubMed PubMed Central Google Scholar
• Scholz, C. C. et al. Regulation of IL-1β-induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways. Proc. Natl Acad. Sci. USA 110, 18490–18495 (2013).
  CAS PubMed PubMed Central Google Scholar
• Cockman, M. E. et al. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl Acad. Sci. USA 103, 14767–14772 (2006).
  CAS PubMed PubMed Central Google Scholar
• Zaph, C. et al. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 446, 552–556 (2007).
  CAS PubMed Google Scholar
• Coleman, M. L. et al. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J. Biol. Chem. 282, 24027–24038 (2007).
  CAS PubMed Google Scholar
• Koditz, J. et al. Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 110, 3610–3617 (2007).
  PubMed Google Scholar
• Bartels, K., Grenz, A. & Eltzschig, H. K. Hypoxia and inflammation are two sides of the same coin. Proc. Natl Acad. Sci. USA 110, 18351–18352 (2013).
  CAS PubMed PubMed Central Google Scholar
• Riegel, A. K. et al. Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood 117, 2548–2555 (2011).
  CAS PubMed PubMed Central Google Scholar
• Idzko, M., Ferrari, D. & Eltzschig, H. K. Nucleotide signalling during inflammation. Nature 509, 310–317 (2014).
  CAS PubMed PubMed Central Google Scholar
• Koeppen, M., Eckle, T. & Eltzschig, H. K. Interplay of hypoxia and A2B adenosine receptors in tissue protection. Adv. Pharmacol. 61, 145–186 (2011).
  CAS PubMed Google Scholar
• Aherne, C. M., Kewley, E. M. & Eltzschig, H. K. The resurgence of A2B adenosine receptor signaling. Biochim. Biophys. Acta 1808, 1329–1339 (2011).
  CAS PubMed Google Scholar
• Faigle, M., Seessle, J., Zug, S., El Kasmi, K. C. & Eltzschig, H. K. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 3, e2801 (2008).
  PubMed PubMed Central Google Scholar
• Eltzschig, H. K. et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ. Res. 99, 1100–1108 (2006).
  CAS PubMed Google Scholar
• Hart, M. L., Gorzolla, I. C., Schittenhelm, J., Robson, S. C. & Eltzschig, H. K. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J. Immunol. 184, 4017–4024 (2010).
  CAS PubMed Google Scholar
• Eltzschig, H. K. et al. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113, 224–232 (2009).
  CAS PubMed PubMed Central Google Scholar
• Thompson, L. F. et al. Crucial role for ecto-5′- nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395–1405 (2004).
  CAS PubMed PubMed Central Google Scholar
• Ahmad, A. et al. Adenosine A2A receptor is a unique angiogenic target of HIF-2α in pulmonary endothelial cells. Proc. Natl Acad. Sci. USA 106, 10684–10689 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K. & Colgan, S. P. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20, 2242–2250 (2006).
  CAS PubMed Google Scholar
• Morote-Garcia, J. C., Rosenberger, P., Nivillac, N. M., Coe, I. R. & Eltzschig, H. K. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 136, 607–618 (2009).
  CAS PubMed Google Scholar
• Eltzschig, H. K. et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202, 1493–1505 (2005).
  CAS PubMed PubMed Central Google Scholar
• Casanello, P. et al. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ. Res. 97, 16–24 (2005).
  CAS PubMed Google Scholar
• Morote-Garcia, J. C., Rosenberger, P., Kuhlicke, J. & Eltzschig, H. K. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111, 5571–5580 (2008).
  CAS PubMed Google Scholar
• Chan, D. A., Sutphin, P. D., Denko, N. C. & Giaccia, A. J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J. Biol. Chem. 277, 40112–40117 (2002).
  CAS PubMed Google Scholar
• McDonough, M. A. et al. Selective inhibition of factor inhibiting hypoxia-inducible factor. J. Am. Chem. Soc. 127, 7680–7681 (2005).
  CAS PubMed Google Scholar
• Wang, G. L. & Semenza, G. L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood. 82, 3610–3615 (1993).
  CAS PubMed Google Scholar
• Knowles, H. J., Tian, Y. M., Mole, D. R. & Harris, A. L. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1α, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ. Res. 95, 162–169 (2004).
  CAS PubMed Google Scholar
• Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl Acad. Sci. USA 99, 13459–13464 (2002).
  CAS PubMed PubMed Central Google Scholar
• Nangaku, M. et al. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler. Thromb. Vasc. Biol. 27, 2548–2554 (2007).
  CAS PubMed Google Scholar
• Zaman, K. et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, 21(waf1/cip1), and erythropoietin. J. Neurosci. 19, 9821–9830 (1999).
  CAS PubMed PubMed Central Google Scholar
• Warshakoon, N. C. et al. Design and synthesis of a series of novel pyrazolopyridines as HIF-1α prolyl hydroxylase inhibitors. Bioorg. Med. Chem. Lett. 16, 5687–5690 (2006).
  CAS PubMed Google Scholar
• Choi, S. M. et al. Clioquinol, a Cu(II)/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1α, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells. J. Biol. Chem. 281, 34056–34063 (2006).
  CAS PubMed Google Scholar
• Siddiq, A. et al. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J. Biol. Chem. 280, 41732–41743 (2005).
  CAS PubMed Google Scholar
• Jiang, B. H. et al. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12, 363–369 (2001).
  CAS PubMed Google Scholar
• Majumder, P. K. et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1- dependent pathways. Nature Med. 10, 594–601 (2004).
  CAS PubMed Google Scholar
• Mie Lee, Y. et al. Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity. Biochem. Biophys. Res. Commun. 300, 241–246 (2003).
  PubMed Google Scholar
• Qian, D. Z. et al. Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α. Cancer Res. 66, 8814–8821 (2006).
  CAS PubMed Google Scholar
• Kong, X. et al. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α. Mol. Cell. Biol. 26, 2019–2028 (2006).
  CAS PubMed PubMed Central Google Scholar
• Hur, E. et al. Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1α/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol. Mol. Pharmacol. 62, 975–982 (2002).
  CAS PubMed Google Scholar
• Osada, M., Imaoka, S. & Funae, Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1α protein. FEBS Lett. 575, 59–63 (2004).
  CAS PubMed Google Scholar
• Mabjeesh, N. J. et al. Geldanamycin induces degradation of hypoxia-inducible factor 1α protein via the proteosome pathway in prostate cancer cells. Cancer Res. 62, 2478–2482 (2002).
  CAS PubMed Google Scholar
• Isaacs, J. S. et al. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway. J. Biol. Chem. 277, 29936–29944 (2002).
  CAS PubMed Google Scholar
• Kaluz, S., Kaluzova, M. & Stanbridge, E. J. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1α C-terminal activation domain. Mol. Cell. Biol. 26, 5895–5907 (2006).
  CAS PubMed PubMed Central Google Scholar
• Yeo, E. J. et al. Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1. Blood. 107, 916–923 (2006).
  CAS PubMed Google Scholar
• Kung, A. L. et al. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell. 6, 33–43 (2004).
  CAS PubMed Google Scholar
• Verma, R. P. & Hansch, C. Camptothecins: a SAR/QSAR study. Chem. Rev. 109, 213–235 (2009).
  CAS PubMed Google Scholar
• Rapisarda, A. et al. Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts. Cancer Res. 64, 6845–6848 (2004).
  CAS PubMed Google Scholar